Enovis ENOV
NYSE ENOV
$19.02 -0.96 (-4.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

Enovis (ENOV) Payout Ratio (2012 - 2013)

Enovis' (ENOV) quarterly Payout Ratio came in at 0.19 in Q3 2013, up 285037.38% quarter-over-quarter from 0.0 in Q4 2012.

Analysis

Enovis (ENOV) Payout Ratio (2012 - 2013) Analysis & Trends

Enovis (ENOV) has reported Payout Ratio for 2 consecutive years, with 0.19 the latest figure, recorded in Q3 2013.

  • On a quarterly basis, Payout Ratio changed N/A year-over-year to 0.19 in Q3 2013; TTM through Dec 2013 was 0.06, a 117.62% increase from a year earlier, with the FY2019 full-year figure at 0.18, changed N/A from the prior year.
  • Payout Ratio was 0.19 for Q3 2013 at Enovis, up from 0.0 in the prior quarter.
  • Over five years, Payout Ratio peaked at 3.73 in Q2 2012 and troughed at 0.02 in Q1 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn
10 Enovis 1.07 Bn 1.06 Bn 359.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2013 0.19
Dec 31, 2012 0.00
Jun 29, 2012 3.73
Mar 30, 2012 -0.02